Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
ChromaDex Corporation
ChromaDex Completes $4.67 Million Capital Raise in Private Placement Transaction
August 23rd, 2008
ChromaDex Corporation (BULLETIN BOARD: CDXC) , a leader in the development of phytochemical and botanical reference standards, announced that on July 29, 2008, it completed its last round of sales under a private placement it conducted with its wholly owned subsidiary ChromaDex, Inc., which consisted of the sale of a unit of one share of common stock and a warrant to purchase one half the shares of common stock purchased for a price of $1.36 per unit. The private placement, which was authorized for up to $6 million and has been on-going since March, yielded gross proceeds of approximately $4.67 million. Net proceeds after expenses are expected to be approximately $4.2 million. New Castle...
Source: Law & Health Weekly (2008-08-23)
|
